back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-02-19 20:20 Tx date 2025-02-14 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$658,987
+200,300 vol $3.29 each |
1,046,400 | |
| Filed 2025-02-19 20:18 Tx date 2025-02-14 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+49,300 vol |
155,494 | |
| Filed 2025-02-05 17:19 Tx date 2025-02-04 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,519.484
-19,348 vol $3.28 each |
106,194 | |
| Filed 2024-03-12 14:44 Tx date 2024-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,077.875
-4,358 vol $2.31 each |
125,542 | |
| Filed 2024-03-12 14:42 Tx date 2024-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+101,000 vol |
129,900 | |
| Filed 2024-03-12 14:41 Tx date 2024-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$969,360
+403,900 vol $2.40 each |
846,100 | |
| Filed 2024-03-12 14:33 Tx date 2023-07-10 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
442,200 | ||
| Filed 2024-03-12 14:29 Tx date 2023-07-10 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
28,900 | ||
| Filed 2024-03-12 13:37 Tx date 2023-07-10 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-12 13:37 Tx date 2023-07-10 |
$ABUS
Arbutus Biopharma Corporation |
Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|